verified SJR 0,642 · Q2 • database Scopus / SJR & Web of Science indexed

United States · Lippincott Williams and Wilk...

workspace_premium Q2 — Psychiatry and Mental Health lock Subscription

International Clinical Psychopharmacology

International Clinical Psychopharmacology is a journal indexed in SJR in Psychiatry and Mental Health and Pharmacology (medical) with an H index of 100. It has an SJR impact factor of 0,642 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,642.

International Clinical Psychopharmacology focuses its scope in these topics and keywords: treatment, patients, study, safety, benzodiazepines, major, antibiotics, efficacy, hospitalized, multiple, ...

ISSN: 0268-1315

Publisher: Lippincott Williams and Wilkins Ltd.

Category: Psychiatry and Mental Health

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,642 Q2

H-index 100

Acceptance rate pie_chart

25% Selective

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

NPD Subscription

Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,642

H-index

100

Docs (year)

Docs 3y

156

Total refs

3240

Cites 3y

314

Citable 3y

138

Cites/Doc 2y

1.95

Ref/Doc

47.65

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Antipsychotic drugs and QT prolongation

Ziprasidone augmentation for anxious depression

Content validity of the Sheehan Irritability Scale in patients with major depressive disorder

Comparative cost-effectiveness of 11 oral antipsychotics for relapse prevention in schizophrenia within Singapore using effectiveness estimates from a network meta-analysis

Clonazepam treatment of lysergic acid diethylamide-induced hallucinogen persisting perception disorder with anxiety features

Clomipramine treatment of delusional disorder, somatic type

Cariprazine in the treatment of schizophrenia

Cardiovascular Effects of Antidepressants

Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale

Assessing efficacy/effectiveness and safety/tolerability profiles of adjunctive pramipexole in bipolar depression

Armodafinil in binge eating disorder

Antipsychotic prescribing patterns in Germany: a retrospective analysis using a large outpatient prescription database

SHOW MORE ARTICLES

Antipsychotic monotherapy and adjuvant psychotropic therapies in schizophrenia patients

A 1-year, double-blind, placebo-controlled trial of ziprasidone 40, 80 and 160???mg/day in chronic schizophrenia: the Ziprasidone Extended Use in Schizophrenia (ZEUS) study

An update of recent moclobemide interaction data

Amisulpride: from animal pharmacology to therapeutic action

Adjunctive lisdexamfetamine in bipolar depression

A randomized, placebo-controlled study of adjunctive ramelteon in ambulatory bipolar I disorder with manic symptoms and sleep disturbance

A randomized, double-blind, multi-centre, parallel-group study comparing the tolerability and efficacy of moclobemide and dothiepin hydrochloride in depressed patients in general practice

A pilot randomized placebo-controlled trial of adjunctive aripiprazole for chronic PTSD in US military Veterans resistant to antidepressant treatment

A double-blind study of the efficacy and safety of sertraline and clomipramine in outpatients with severe major depression

A Double-Blind Multicentre Study of Paroxetine and Amitriptyline in Depressed Outpatients

A double-blind comparison of moclobemide and fluoxetine in the treatment of depressive disorders

A detailed longitudinal analysis on the use of naltrexone in the treatment of bulimia

FAQs

International Clinical Psychopharmacology has an SJR of 0,642 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is not available (NPD).

The acceptance rate recorded for International Clinical Psychopharmacology is 25%.

International Clinical Psychopharmacology

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of International Clinical Psychopharmacology?

What is the APC / publication cost?

What is the acceptance rate?